Search Results
Aug 26, 2026, 07:00 ET HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
A, Laversanne M, Marcos-Gragera R et al. The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045. J Natl Cancer Inst. 2025 May 1;117(5):907-914.[2] Bray F, Laversanne M, Sung H, et al. Global cancer statistics
More news about: HaemaLogiX Ltd
Jul 27, 2026, 09:05 ET BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
Under the agreement, BioMarin and n-Lorem will collaborate to advance an investigational ASO candidate targeting the RNU4-2 (n.64_65insT) variant, which is estimated to account for approximately 75% of ReNU syndrome cases. ReNU syndrome was first discovered in 2024 by an international
More news about: BioMarin Pharmaceutical Inc.
Jul 09, 2026, 08:00 ET Freenome Reports Top-Line Readout of Updated SimpleScreen™ CRC Colorectal Cancer Screening Blood Test Met All Primary and Secondary Endpoints
Cancer. JAMA. Published online June 2, 2025. doi: 10.1001/jama.2025.7515.2. Data on file.3. Meester RGS et al. JNCI J Natl Cancer Inst. 2026;118(1):113-120.4. Data on file.
More news about: Freenome Holdings, Inc.
Jul 09, 2026, 06:01 ET Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer
received a marketing authorisation in any country or region.References:Gallichio L et al, JNCI J Natl Cancer Inst (2022) 114(11): djac158SEER 22 database, https://seer.cancer.gov/statfacts/html/prost.html,
More news about: Blue Earth Therapeutics
Jun 24, 2026, 09:31 ET Ethlabs Didirikan Oleh Mantan Kontributor Ethereum Foundation Dan Didanai Oleh Bitmine, Sharplink, Dan Joe Lubin. Ethlabs Diluncurkan Untuk Mempercepat Gelombang Besar Penggunaan Ethereum Di Kalangan Institusi
multimedia:https://www.prnewswire.com/id/rilis-berita/ethlabs-didirikan-oleh-mantan-kontributor-ethereum-foundation-dan-didanai-oleh-bitmine-sharplink-dan-joe-lubin-ethlabs-diluncurkan-untuk-mempercepat-gelombang-besar-penggunaan-ethereum-di-kalangan-institusi-302809334.htmlSOURCE
More news about: Ethlabs
Jun 23, 2026, 02:00 ET Nordiska Elevates its Payments Infrastructure with Finastra, Powering Direct Connectivity to Sweden's Payment Rails
Finastra's Swift Service Bureau enables a secure, compliant, and resilient foundation to support its current operations and future growth including RIX INST accessSTOCKHOLM, June 23, 2026 /PRNewswire/ -- Bankaktiebolaget Nordiska
More news about: Finastra
Mar 24, 2026, 08:00 ET John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening
https://jamanetwork.com/journals/jama/fullarticle/2844189Itzkowitz, S. Incremental advances in excremental cancer detection. J Natl Cancer Inst. 2009 Sep 16;101(18):1244-58.Cologuard Plus™ Clinician Brochure. Madison, WI: Exact Sciences Corporation.
More news about: Abbott
Mar 13, 2026, 00:39 ET Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard® Tests to Expand Reach
Years. JAMA. 2026;335(7):632–634. doi:10.1001/jama.2025.25467Itzkowitz SH. Incremental advances in excremental cancer detection tests. J Natl Cancer Inst. 2009;101(18):1225-1227.Survival rates for colorectal cancer. American Cancer Society. Updated January 29, 2024. Accessed October 9, 2025.
More news about: Workflow Services
Mar 05, 2026, 06:00 ET Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients
trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.Endnotes and ReferencesMilken Inst Waters H et al America Obesity Crisis Oct 2018.International Foundation of Employee Benefit Plans. Pulse Survey: GLP-1 Drugs Coverage.
More news about: Eli Lilly and Company
Jan 20, 2026, 08:05 ET Redox Bio-Nutrients becomes First Company to have Two Certified Biostimulant Products
@Fertilizer_Inst. Learn more about TFI's nutrient stewardship initiatives at
More news about: Redox Bio-Nutrients
Jan 15, 2026, 06:01 ET First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate Resistant Prostate Cancer
https://www.blueearththerapeutics.com/newsNCT04647526, NCT05204927, NCT04720157, NCT04689828Gallichio L et al, JNCI J Natl Cancer Inst (2022) 114(11): djac158SEER 22 database, https://seer.cancer.gov/statfacts/html/prost.htmlContact:
More news about: Blue Earth Therapeutics Limited
Nov 13, 2025, 14:00 ET Pearl Diver Capital Announces the First Close of "Pearl Diver Aquanaut Fund" a Global Interval Fund Dedicated to Significant Risk Transfer (SRT) Investments and Capital Relief transactions for financial institutions
multimedia:https://www.prnewswire.com/news-releases/pearl-diver-capital-announces-the-first-close-of-pearl-diver-aquanaut-fund-a-global-interval-fund-dedicated-to-significant-risk-transfer-srt-investments-and-capital-relief-transactions-for-financial-institutions-302614891.html
More news about: Pearl Diver Capital
Oct 20, 2025, 09:00 ET Lecturio Acquires SimTutor to Expand its Digital Healthcare Training Portfolio
www.lecturio.com/inst. About SimTutorSimTutor is a provider of simulation-based learning tools that
More news about: Lecturio GmbH
Oct 07, 2025, 03:00 ET Blue Earth Therapeutics Presents Modelling Data Supporting Early Dose Intensification of Lutetium (177Lu) rhPSMA-10.1 Injection in mCRPC
Gallichio L et al, JNCI J Natl Cancer Inst (2022) 114(11): djac158
More news about: Blue Earth Therapeutics
Oct 07, 2025, 03:00 ET Blue Earth Therapeutics Presents Modelling Data Supporting Early Dose Intensification of Lutetium (177Lu) rhPSMA-10.1 Injection in mCRPC
Gallichio L et al, JNCI J Natl Cancer Inst (2022) 114(11): djac158
More news about: Blue Earth Therapeutics
Sep 12, 2025, 10:01 ET Europe Real-Time Payments Market Poised for USD 17.45B by 2033, Presenting High-Growth Investment Opportunities | DataM Intelligence
more than 60% of European consumers reported preferring instant confirmation for digital transactions, while the SEPA Instant Credit Transfer (SCT Inst) scheme processed transactions worth billions of euros monthly across the Eurozone. The introduction of the EU Instant Payments Regulation (2024) further
More news about: DataM Intelligence 4 Market Research LLP